Prognostic Factors for Local Control in Breast Cancer With Boost vs No Boost
Interview with Conny Vrieling, MD PhD, author of Prognostic Factors For Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"JAMA Oncology Author Interviews","authorlink":""},"src":"http:\/\/traffic.libsyn.com\/jamaoncologyauthorinterviews\/Prognostic_Factors_for_Local_Control_in_Breast_Cancer_With_Boost_vs_No_Boost_JAMA_Oncology.mp3?dest-id=422099","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202106\/248e5d-db09-5ea9-5a2c40_800.png"},"title":"Prognostic Factors for Local Control in Breast Cancer With Boost vs No Boost","link":"javascript:;","id":"item-438015"}]
